Biotech & Medtech
Biotech & Medtech news — Monday 26 October 2026
37 stories from 5 sources, every one in English. Each links to its publisher.
-
STAT+: HHS relaxes security, transparency rules for health record software used by hospitals
STAT News
The Trump administration on Monday removed 14 security, privacy and transparency requirements for vendors of electronic health records, with the goal of streamlining government regulations and supporting the development of new…
-
Obesity Biotech Corxel Is Going Public in a Merger as Oral GLP-1 Heads to Phase 3
MedCity News
Corxel Pharmaceuticals is catching up to others with oral GLP-1 obesity drugs, but the biotech claims its small molecule could offer better tolerability compared to the rest of its class. The SPAC merger taking Corxel public is expected to…
-
Corxel, an obesity drugmaker, to go public via SPAC deal
BioPharma Dive
Armed with a $300 million financing and two GLP-1 and amylin-targeting medicines, Corxel is set to become the latest weight loss-focused company to join the public markets.
-
Sutter Health Expands Remote Monitoring Program to Patients with Heart Failure
MedCity News
Sutter Health, a nonprofit healthcare system based in Sacramento, California, is expanding its digital chronic disease management program, Sutter Sync, to include patients with heart failure. The expansion adds a remote monitoring…
-
STAT+: House lawmaker probes PBMs for ‘punitive’ audits of independent pharmacies
STAT News
A House lawmaker is investigating whether the three largest pharmacy benefit managers targeted independent pharmacies with audits in retaliation for supporting a bill that would require the companies to adjust payments to the retailers…
-
STAT+: GSK sees its return to cancer start to pay off
STAT News
MADRID — In the past week, a GSK cancer drug picked up an approval for another tumor type, the company unveiled the first data from a global study of a promising next-generation chemotherapy, and a medicine that the firm has licensed got…
-
BioNTech, DualityBio say ADC had ‘modest’ benefit in breast cancer study
BioPharma Dive
The companies said the findings suggest the treatment has a “limited” impact in HER2-low breast cancer, an area where AstraZeneca and Daiichi Sankyo’s Enhertu has already set a high bar.
-
ESMO ‘26: A cancer vaccine debate, Roche’s KRAS progress and Amgen’s ‘unprecedented’ data
BioPharma Dive
At one of the year’s premiere meetings for cancer research, melanoma vaccine data hailed by scientists sparked a share sell-off on Wall Street, while a lung drug received a standing ovation.
-
STAT+: Merck ADC drug cut risk of death by one-third in advanced endometrial cancer
STAT News
MADRID — A type of targeted chemotherapy developed by Merck and China’s Kelun-Biotech cut by one-third the risk of death in patients with advanced endometrial cancer, a common gynecological cancer, according to randomized Phase 3 study…
-
STAT+: Rising premiums, a sad Medicaid gathering, and a new fraud crackdown
STAT News
This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here . This is Tara, filling in for Bob. And no, I haven’t yet seen “You Can See Everything,” but a bunch of my colleagues did and here’s what they…
-
Another autoimmune CAR-T death; Treasury zeroes in on China deals
BioPharma Dive
A patient who received Bristol Myers’ zola-cel died 44 days later. Elsewhere, Gilead paid nearly $1.3 billion for a potential threat to J&J’s newly approved psoriasis pill.
-
STAT+: Incyte pancreatic cancer medicine induces lasting tumor responses, company says at ESMO
STAT News
MADRID — A targeted drug from Incyte, when used in combination with chemotherapy, induced lasting tumor responses in certain patients with pancreatic cancer — results, the biotech said, that support its prior decision to advance the…
-
STAT+: Five biotech updates to read after ESMO this weekend
STAT News
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Soundtrack at present: Iggy Pop, The Idiot . Moderna CEO sees vaccine possibility beyond melanoma Moderna CEO…
-
STAT+: Pharmalittle: We’re reading about a Roche lung cancer drug, a Bristol CAR-T trial death, and more
STAT News
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-too-familiar routine of meetings, deadlines, and the like has returned with a vengeance. But what can…
-
A virus that afflicts cows makes the jump to a human
STAT News
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here . I know we’ve had a lot of “You Can See Everything” content in this newsletter, but allow me one more plug. A recent STAT…
-
In a Maternity Care Crisis, CMS Undermines Efforts To Modernize Care
MedCity News
CMS has introduced uncertainty about whether Medicare will participate in that modernization or preserve the old system under a different name. The consequences extend far beyond billing The post In a Maternity Care Crisis, CMS Undermines…
-
FDA Alignment Is a Starting Point, Not a Rare Disease Strategy for the European Market
MedCity News
[Sponsored] For US biotech companies developing rare disease therapies, decisions about clinical evidence, patient populations and regulatory advice can have consequences in Europe long before a marketing application is submitted. The post…
-
The molecule was fine. The moment wasn’t.
BioPharma Dive
Some overlooked medicines aren’t failures. They just arrived before the market was ready.
-
The 4 stages of women’s heart health: Experts present new framework
STAT News
Women’s hearts are different from men’s. Research from clinical trials that have required female participants only since 1993 have repeatedly drummed home that message, from varying chromosomes in heart muscle cells to different heart…
-
Novel protein and peptide therapeutics
BioPharma Dive
Explore manufacturing challenges and solutions for ADCs, bispecifics, peptides and more.
-
STAT+: Moderna CEO on what’s next after success in cancer vaccine
STAT News
MADRID — Moderna CEO Stéphane Bancel had every reason to be smiling and happy on a brilliantly sunny Saturday afternoon here in Spain’s capital. In a couple of hours, a decade of the company’s research — boosted by a partnership with Merck…
-
Opinion: Could long-term AI use lead to isolation? We need to find out — but researchers need better access to data
STAT News
OpenAI recently announced that it is tracking signs of user distress across sessions, rather than only within them, and using that information to inform model responses. The announcement follows a wave of new safeguards for mental health…
-
STAT+: NIH’s new vaccine injury center has broad goals beyond RFK Jr.’s focus on shots
STAT News
WASHINGTON — Earlier this month at a private event, Robert F. Kennedy Jr. and other top federal health officials announced a new National Institutes of Health center that would focus on patients with vaccine injuries, drawing fresh…
-
Opinion: How bad is healthy supposed to feel?
STAT News
The 43-year-old woman sitting across from me in my exam room is exasperated. “I just don’t feel like I have the energy or stamina I used to,” she tells me. “I could run 5 miles a day no problem when I was 23.” Today we are reviewing her…
-
A Resource-Efficient and Precision-Scalable FPGA Accelerator for Spiking Neural Networks Using Minifloat Arithmetic
arXiv cs.NE (Neural／Bio)
arXiv:2610.32052v1 Announce Type: new Abstract: Spiking neural networks (SNNs) are well suited to event-driven edge intelligence, but the arithmetic complexity, memory footprint, and power consumption associated with conventional…
-
Frame Theoretical Derivation of Three Factor Learning Rule for Oja's Subspace Rule
arXiv cs.NE (Neural／Bio)
arXiv:2604.02849v2 Announce Type: replace Abstract: We show that the error-gated Hebbian rule for PCA (EGHR-PCA), a three-factor learning rule equivalent to Oja's subspace rule under Gaussian inputs, can be systematically derived from…
-
Softly Symbolifying Kolmogorov-Arnold Networks
arXiv cs.NE (Neural／Bio)
arXiv:2512.07875v2 Announce Type: replace-cross Abstract: Kolmogorov--Arnold Networks (KANs) offer a promising path toward interpretable machine learning: their learnable activations can be studied individually while collectively fitting…
-
Bio-Inspired Auditory Processing: Coupling Parallel Resonate-and-Fire Dynamics with Ternary Recurrent Networks for Speech Recognition
arXiv cs.NE (Neural／Bio)
arXiv:2610.29720v2 Announce Type: replace-cross Abstract: Spiking Neural Networks (SNNs) promise energy-efficient inference through sparse, event-driven computation, yet remain constrained on continuous, context-dependent tasks such as…
-
RobustNCL: Robustifying Neuromorphic Continual Learning under Transient Faults with Lightweight Detect-and-Cure Strategy
arXiv cs.NE (Neural／Bio)
arXiv:2610.31954v1 Announce Type: new Abstract: In neural networks, continual learning (CL) is a prominent approach for enabling deployed systems to adapt to dynamic operational environments by effectively learning from new unseen data at…
-
Algorithm Modelization: Transforming Optimization Algorithms into Evolvable Intelligence
arXiv cs.NE (Neural／Bio)
arXiv:2610.23161v2 Announce Type: replace-cross Abstract: Can algorithms be learned and evolved as models, rather than repeatedly redesigned as programs? We explore this question by introducing Algorithm Modelization, a new paradigm that…
-
Reconstructing Backpropagation from Forward Fluctuations in Noise-modulated Neural Networks
arXiv cs.NE (Neural／Bio)
arXiv:2607.26483v2 Announce Type: replace Abstract: A Noise-modulated Neural Network (NNN) learns and infers only in the presence of noise, treating noise as a computational resource rather than a disturbance. The noise lets it learn…
-
Isotropic Activation Functions Enable Deindividuated Neurons and Adaptive Topologies
arXiv cs.NE (Neural／Bio)
arXiv:2602.23405v3 Announce Type: replace Abstract: Varying the number of neurons while preserving function is difficult because neural networks' dense connectivity creates strong computational interdependence between units. Elementwise…
-
On Orthogonal Recurrent Neural Networks Quantization
arXiv cs.NE (Neural／Bio)
arXiv:2402.04012v3 Announce Type: replace Abstract: In recent years, Orthogonal Recurrent Neural Networks (ORNNs) have gained popularity due to their ability to manage tasks involving long-term dependencies, such as the Copy-task, and…
-
Searching with Sparse Histories: Cross-Task Architecture Search from Incomplete Search Logs and Zero-Cost Proxies
arXiv cs.NE (Neural／Bio)
arXiv:2610.32179v1 Announce Type: cross Abstract: Neural architecture search (NAS) is expensive, but cross-task transfer can reduce costs by reusing knowledge from previous tasks. However, existing methods struggle with sparse search…
-
ENCL: Enabling Efficient Neuromorphic Continual Learning with Local Learning Rule and Sub-Network Freezing Strategy
arXiv cs.NE (Neural／Bio)
arXiv:2610.31927v1 Announce Type: new Abstract: Continual learning (CL) in neural networks is a promising learning approach for updating the knowledge of deployed systems based on new data encountered at run time, that have not been…
-
PAFS: Perturbation-Aware Firing Scaffolds for Robust Event-Based SNNs
arXiv cs.NE (Neural／Bio)
arXiv:2610.32409v1 Announce Type: new Abstract: Event-based spiking neural networks (SNNs) encode information through temporal firing dynamics, but the same stateful computation makes their predictions sensitive to event loss, timestamp…
-
Giving AI a seat at the peer review table
Nature Biotechnology
Nature Biotechnology, Published online: 26 October 2026; doi:10.1038/s41587-026-03369-w Giving AI a seat at the peer review table